Journal Article Epublish 97 citations
PubMed: 33435351 DOI: 10.3390/metabo11010044
Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets.
Metabolites 11(1)
Authors: Zhiqiang Pang, Guangyan Zhou, Jasmine Chong, Jianguo Xia
Affiliations
- Institute of Parasitology, McGill University, 21111 Lakeshore Road, Ste Anne de Bellevue, QC H9X 3V9, Canada.
- Institute of Parasitology, McGill University, 21111 Lakeshore Road, Ste Anne de Bellevue, QC H9X 3V9, Canada. Department of Animal Science, McGill University, 21111 Lakeshore Road, Ste Anne de Bellevue, QC H9X 3V9, Canada.
Abstract
The novel coronavirus SARS-CoV-2 has spread across the world since 2019, causing a global pandemic. The pathogenesis of the viral infection and the associated clinical presentations depend primarily on host factors such as age and immunity, rather than the viral load or its genetic variations. A growing number of omics studies have been conducted to characterize the host immune and metabolic responses underlying the disease progression. Meta-analyses of these datasets have great potential to identify robust molecular signatures to inform clinical care and to facilitate therapeutics development. In this study, we performed a comprehensive meta-analysis of publicly available global metabolomics datasets obtained from three countries (United States, China and Brazil). To overcome high heterogeneity inherent in these datasets, we have (a) implemented a computational pipeline to perform consistent raw spectra processing; (b) conducted meta-analyses at pathway levels instead of individual feature levels; and (c) performed visual data mining on consistent patterns of change between disease severities for individual studies. Our analyses have yielded several key metabolic signatures characterizing disease progression and clinical outcomes. Their biological interpretations were discussed within the context of the current literature. To the best of our knowledge, this is the first comprehensive meta-analysis of global metabolomics datasets of COVID-19.
MeSH
Infections, Disease Progression, Coronavirus, Metabolomics, Covid-19
Cited by
- Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies. Int J Mol Sci, 2021
- Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection. Viruses, 2022
- H qNMR-Based Metabolomics Discrimination of Covid-19 Severity. J Proteome Res, 2022
- Metabolomic characterization of congenital microtia: a possible analysis for early diagnosis. Ann Transl Med, 2023
- Quantitative Serum NMR Spectroscopy Stratifies COVID-19 Patients and Sheds Light on Interfaces of Host Metabolism and the Immune Response with Cytokines and Clinical Parameters. Metabolites, 2022
- Quantitative Comparison of Statistical Methods for Analyzing Human Metabolomics Data. Metabolites, 2022
- Biological and Clinical Factors contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19. Res Sq, 2021
- Metabolic Profiling from an Asymptomatic Ferret Model of SARS-CoV-2 Infection. Metabolites, 2021
- Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry. Metabolism, 2021
- Genome-wide identification and expression profiling of durian CYPome related to fruit ripening. PLoS One, 2022
- Label-Free SERS for Rapid Differentiation of SARS-CoV-2-Induced Serum Metabolic Profiles in Non-Hospitalized Adults. Anal Chem, 2023
- Integrated Metabolic and Inflammatory Signatures Associated with Severity of, Fatality of, and Recovery from COVID-19. Microbiol Spectr, 2023
- Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation. Front Immunol, 2022
- Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS. Crit Care, 2021
- Repurposing the memory-promoting meclofenoxate hydrochloride as a treatment for Parkinson's disease through integrative multi-omics analysis. NPJ Parkinsons Dis, 2025
- Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19. Sci Rep, 2021
- An Innate Checkpoint Determines Immune Dysregulation and Immunopathology during Pulmonary Murine Coronavirus Infection. J Immunol, 2023
- Molecular perturbations in pulmonary tuberculosis patients identified by pathway-level analysis of plasma metabolic features. PLoS One, 2022
- Assessing Dynamic Changes of Taste-Related Primary Metabolism During Ripening of Durian Pulp Using Metabolomic and Transcriptomic Analyses. Front Plant Sci, 2021
- Plasma metabolomics and gene regulatory networks analysis reveal the role of nonstructural SARS-CoV-2 viral proteins in metabolic dysregulation in COVID-19 patients. Sci Rep, 2022